Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
3
×
boston blog main
clinical trials
fda
life sciences
3
×
national blog main
boston top stories
national top stories
new york blog main
new york top stories
san francisco blog main
akcea therapeutics
akouos
allopregnanolone
alnylam pharmaceuticals
andrew fire
astellas pharmaceuticals
biotech
brexanolone
california institute for biomedical research
craig mello
deals
decibel therapeutics
drugs
frequency therapeutics
harvard university
hearing loss
hereditary transthyretin amyloidosis
inotersen
investing
jeffrey karp
john maraganore
marc goodman
marinus pharmaceuticals
mike cloonan
multiple sclerosis
nobel prize
onpattro
patisiran
perceptive life sciences
What
approved
3
×
drug
3
×
fda
medicine
specifically
affects
afternoon
alnylam
alnylam’s
americans
brexanolone
date
depression
devastating
developing
disorder
fast
frequency
gets
hearing
history
ipo
landmark
loss
making
medicines
meds
millions
moms
new
ok
oks
onpattro
partum
patisiran
pharmaceuticals
plans
post
potentially
regenerative
Language
unset
Current search:
approved
×
drug
×
boston
×
" life sciences "
×
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug